1. Home
  2. GROW vs IGC Comparison

GROW vs IGC Comparison

Compare GROW & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • IGC
  • Stock Information
  • Founded
  • GROW 1968
  • IGC 2005
  • Country
  • GROW United States
  • IGC United States
  • Employees
  • GROW N/A
  • IGC N/A
  • Industry
  • GROW Investment Managers
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROW Finance
  • IGC Health Care
  • Exchange
  • GROW Nasdaq
  • IGC Nasdaq
  • Market Cap
  • GROW 36.8M
  • IGC 32.5M
  • IPO Year
  • GROW N/A
  • IGC N/A
  • Fundamental
  • Price
  • GROW $2.61
  • IGC $0.43
  • Analyst Decision
  • GROW
  • IGC Strong Buy
  • Analyst Count
  • GROW 0
  • IGC 1
  • Target Price
  • GROW N/A
  • IGC $3.25
  • AVG Volume (30 Days)
  • GROW 24.4K
  • IGC 171.5K
  • Earning Date
  • GROW 05-09-2024
  • IGC 08-08-2024
  • Dividend Yield
  • GROW 3.40%
  • IGC N/A
  • EPS Growth
  • GROW 100.00
  • IGC N/A
  • EPS
  • GROW 0.12
  • IGC N/A
  • Revenue
  • GROW $11,854,000.00
  • IGC $1,345,000.00
  • Revenue This Year
  • GROW N/A
  • IGC $5.06
  • Revenue Next Year
  • GROW N/A
  • IGC N/A
  • P/E Ratio
  • GROW $21.67
  • IGC N/A
  • Revenue Growth
  • GROW N/A
  • IGC 47.64
  • 52 Week Low
  • GROW $2.47
  • IGC $0.25
  • 52 Week High
  • GROW $3.30
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • GROW 51.12
  • IGC 47.56
  • Support Level
  • GROW $2.55
  • IGC $0.40
  • Resistance Level
  • GROW $2.65
  • IGC $0.45
  • Average True Range (ATR)
  • GROW 0.04
  • IGC 0.04
  • MACD
  • GROW 0.01
  • IGC 0.00
  • Stochastic Oscillator
  • GROW 59.88
  • IGC 25.75

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company furnishes an investment program for each of the clients it manages and determines, subject to overall supervision by the applicable board of trustees of the clients, the clients investments pursuant to an advisory agreement. US Global manages the following business segments: Investment management services; Investment management services; and Corporate Investments. It derives all its revenue from Investment management services.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: